Perrigo CEO Patrick Lockwood-Taylor Resigns After Board Cites Personal Conduct; Albert Manzone Named Interim Chief
Perrigo Company plc announced Monday, June 8 that president and CEO Patrick Lockwood-Taylor has resigned, after the board determined that "certain personal conduct" by him was not consistent with the company's Code of Co.
At a glance
- Perrigo announced on June 8, 2026 that president and CEO Patrick Lockwood-Taylor resigned.
- The board determined that 'certain personal conduct' by Lockwood-Taylor was not consistent with the company's Code of Conduct and core values.
- Perrigo said the conduct did not involve the company's business, strategy, operations, financial reporting or results of operations.
- Albert A. Manzone was appointed interim president and CEO, effective June 8, 2026, and a search for a permanent successor is underway.
- The transition was disclosed via an investor press release and a Form 8-K material-event filing with the SEC.
VERDICT — CONFIRMED
Perrigo Company plc announced Monday, June 8 that president and CEO Patrick Lockwood-Taylor has resigned, after the board determined that "certain personal conduct" by him was not consistent with the company's Code of Conduct and core values. The Dublin-headquartered consumer self-care products maker — whose largest U.S. operations sit in West Michigan — emphasized that the conduct did not involve Perrigo's business, strategy, operations, financial reporting or results of operations. The board appointed Albert A.
Manzone as interim president and CEO and launched a search process to identify a permanent successor, disclosing the transition in an investor press release and an accompanying Form 8-K material-event filing with the SEC the same day. MarketScreener listed the CEO change as effective June 8, 2026. Local broadcaster WWMT, which covers Perrigo's Allegan-area operations, reported that company officials confirmed the resignation Monday and tied it directly to the board's code-of-conduct determination.
The company offered no further detail on the nature of the conduct and disclosed no severance terms in the announcement, leaving investors to parse the deliberately sparse filing language. The exit adds Perrigo to a growing 2026 roster of conduct-related chief executive departures across consumer health and pharma.
Why it matters
a board forcing out a sitting CEO over personal conduct — while explicitly ring-fencing the financials — is a textbook disclosure-driven executive-move story, and the terse 8-K guarantees follow-on scrutiny of what the board knew and when.
Key facts on file
- Perrigo announced on June 8, 2026 that president and CEO Patrick Lockwood-Taylor resigned.
- The board determined that 'certain personal conduct' by Lockwood-Taylor was not consistent with the company's Code of Conduct and core values.
- Perrigo said the conduct did not involve the company's business, strategy, operations, financial reporting or results of operations.
- Albert A. Manzone was appointed interim president and CEO, effective June 8, 2026, and a search for a permanent successor is underway.
- The transition was disclosed via an investor press release and a Form 8-K material-event filing with the SEC.
